Positive effects of the immunomodulatory therapy in rehabilitation of children with congenital cleft lip and cleft palate on stages of the surgical treatment

Cite item


One of the priority areas in the treatment of children with congenital cleft lip and palate (CLP), suffering a high frequency of repeated acute viral and bacterial infections of the respiratory tract and ENT organs is the task of increasing the effectiveness of stage rehabilitation while reducing postoperative complications and restoring the functional activity of impaired segments of immune system. In the study was developed program of immunomodulatory Likopid therapy in the pre- and postoperative period, which showed a positive effect on the state of all the immune system elements, as well as the clinical effects, which is expressed in decreasing the frequency of acute respiratory viral infection, reducing the number of exacerbations of chronic foci of bacterial infection of the oral cavity and nasopharynx, regression of the number of postoperative complications, reducing hospital stay, reducing not only the number of courses of antibiotic therapy, but also the duration of antibiotic usage. Inclusion in the program of stage-by-stage rehabilitation of children with congenital CLP immunomodulatory therapy allowed to significantly optimize therapeutic tactic, first of all to provide timely surgical care to children with this pathology and to avoid negative clinical consequences during the recovery phase after surgical treatment, and at the same time increase resistance to respiratory infections.

About the authors

Marina N Mitropanova

Kuban State Medical University

Author for correspondence.
Email: mmitropanova@mail.ru

PhD, MD, Associate Professor, Head. Department of Pediatric Dentistry, Orthodontics and Oral and Maxillofacial Surgery, FGBOU VO “Kuban State Medical University” of the Ministry of Health of the Russian Federation


  1. Koenders M., Lubberts E., Oppers-Walgreen В е.а. Blocking of IL17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and IL-1. Am. J. Pathol. 2005. Vol. 167. P. 141—149.
  2. Marcus R., Feldman D., Nelson D. et al. Fundamentals of osteoporosis. 3rd ed., Vol. 1. San Diego: Elsevier. 2008. P. 1941.
  3. Marie-P.J. Osteoblasts and bone formation. Advances in organ biology: molecular and cellular biology of bone. Stamford, CT (USA): JAI Press, 1999. № 5B. P. 401—427.
  4. Seibel M.J., Robins S.P., Bilezikian J.P. Dynamics of bone and cartilage metabolism. 2nd ed. San Diego: Elsevier. 2006. P. 919.
  5. Mitropanova M.N. Functioning pecularities of the immune system in children suffering from the congenital cheilognathopalatoschisis on stages of the surgical treatment. Pediatric Dentistry and Prevention. 2017. Vol. XVI, 2(61). pp 79—83.
  6. Nesterova I.V., Kovaleva S.V., Chudilova G.A., Lomtatidze L.V., Malinovskaj V.V. The positive transformation of the phenotype, the functional activity of neutrophilic granulocytes in children with recurrent respiratory infections as treatment’ results of interferon and immunomodulation therapy. Allergy, asthma & immunophysiology: recent advances in understanding and management (Singapore — April 26—29, 2015). MEDIMOND International Proceedings, 2015. P. 69—72.
  7. Nesterova I.V., Malinovskaya V.V., Tarakanova V.A., Kovaleva S.V. Interferon- and immunotherapy in practical treatment of children and adults suffering from frequent and prolonged diseases. M.: Capricorn Publishing Inc. 2004. 160 с.
  8. Karaulov A.V., Kokushkov D.V. Immunomodulators: classification, principles and practical usage by the infections of the respiratory tract in children. Infantile infections. 2007. № 6 (4). P. 68—74.
  9. Nesterova I.V., Kleshenko E.I., Kovaleva S.V. et al. Concerns of treatment of the virobacterial infections in immunocompromised children suffering from frequent and prolonged diseases. Russian allergological journal. 2011. № 2. Р. 86—93.
  10. Nesterova I.V., Chudilova G.A., Kovaleva S.V., Lomtatidze L.V., Kolesnikova N.V., Evglevskiy A.A. Methods of the complex evaluation of the functional activity of neutrophilic granulocytes in their normal and pathological state: methodological recommendations. Krasnodar, 2017. 50 p.
  11. Pinegin B.V., Andronova T.M., Karsonova M.A. Remedies of muramildipeptide chain — immunotropic medications of the next generation. In: Anniversary collection of scientific articles «Lycopide in the complex program of immunodeficiency disorders». Moscow: 2005. Р. 19—36.
  12. Nesmeyanov V.A. Glucosmuramildipeptide: on the way to understanding the molecular mechanism of biological activity. International journal of immunorehabilitation. 1998. № 10. Р. 19—29.
  13. Haitov R.M. The main aim of immunomodulatory action of the GMDP (Lycopide). Immunology. 1994. № 2. Р.47—50.
  14. Meshceryakova E., Makarov E., Philpott D., Andronova T., Ivanov V. Evidence for correlation between the intensities of adjuvant effects and NOD2 activation by monomeric, dimeric and lipophilic derivates of N-acetilglucosavinyl-N-acetilmuramyl peptides. Vaccine. 2007. № 25. Р. 4515—4520.
  15. Clarke Т.В. Early Innate Immunity to Bacterial Infection in the Lung Is Regulated Systemically by the Commensal Microbiota via Nod-Like Receptor Ligands. Infect Immun. 2014. № 82(11). Р. 4596—4606.
  16. Nesterova I.V., Kovaleva S.V., Kleshenko E.I., Chudilova G.A., Lomtatidze L.V., Shinkareva O.N, Parfenov V.V., Koltzov V.D. The strategy optimization of the interferon- and immunotherapy in rehabilitation of immunocompromised children suffering from the respiratory and herpetic viral reinfections. Pediatrics. 2014. V. 93. № 3. P. 66—72.
  17. Savenkova M.S., Afanasyeva A.A., Abramova N.A. Immunotherapy: treatment and prevention of viral infections in children and adults suffering from frequent and prolonged diseases. Allergology and immunology. 2012. № 1 (1). Р. 20—27.
  18. Nesterova I.V, Kovaleva S.V., Kolesnikova N.V and others. Effectiveness of program in interferon and immunotherapy in children suffering from the associated acute viral respiratory reinfections, herpetic viral reinfections and chronic diseases of the ENT-organs. Russian allergological journal. 2013. № 2 (2). Р. 213—216.
  19. Nesterova I.V., Kovaleva S.V., Kolesnikova N.V., Kleshchenko E.I., Shinkareva O.N, Chudilova G.A., Lomtatidze L.V., Kokova L.N. Optimization of interferon- and immunotherapy in immunocompromised children with associated viral infections. Allergy, asthma & immunophysiology: from basic science to clinical management. Medimond International Proceedings. 2013. P. 101—104.

Copyright (c) 2018 Mitropanova M.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies